NEW YORK, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Alnylam Pharmaceuticals, Inc., MGT Capital Investments, Inc., and Applied Optoelectronics, Inc. Stockholders have until the deadlines listed below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY)
Class Period: February 15, 2018 - September 12, 2018
Lead Plaintiff Deadline: November 26, 2018
The complaint alleges that throughout the Class Period, defendants made materially false and misleading statements regarding the company’s business, operational and compliance policies. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (1) Alnylam overstated the efficacy and safety of its Onpattro (patisiran) lipid complex injection; and (2) as a result, Alnylam’s public statements were materially false and misleading at all relevant times.
To learn more about the Alnylam investigation go to: http://bespc.com/alny/.
MGT Capital Investments, Inc. (Other OTC: MGTI)
Class Period: October 9, 2015 - September 7, 2018
Lead Plaintiff Deadline: November 27, 2018
The complaint alleges that throughout the Class Period, defendants made false and misleading statements to the market. The SEC filed a lawsuit against a former MGT Capital officer and others alleging a pump & dump scheme to artificially drive up the price of the Company’s stock price. The management of MGT Capital was influenced by the scheme, ultimately resulting in the Company’s stock being delisted by the New York Stock Exchange.
To learn more about the MGT class action go to: https://bespc.com/mgti/.
Applied Optoelectronics, Inc. (NASDAQ: AAOI)
Class Period: August 7, 2018 - September 27, 2018
Lead Plaintiff Deadline: November 30, 2018
The Complaint alleges that, throughout the Class Period, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, defendants failed to disclose to investors: (1) that certain of the company’s lasers were susceptible to fail prematurely; (2) that certain of the company’s transceivers utilizing these lasers would be materially affected; and (3) that, as a result of the foregoing, defendant’s positive statements about the company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
To learn more about the AAOI class action go to: http://bespc.com/aaoi/.
Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information about Bragar Eagel & Squire, P.C. please go to www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts
Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com